Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-003265
Filing Date
2019-02-12
Accepted
2019-02-12 16:15:38
Documents
1
Period of Report
2019-02-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4242
  Complete submission text file 0000899243-19-003265.txt   5643
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O APELLIS PHARMACEUTICALS, INC. 6400 WESTWIND WAY, SUITE A CRESTWOOD KY 40014
Business Address
Grossi Federico (Reporting) CIK: 0001720634 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 19590969